RESUMEN
Babesiosis caused by Babesia spp. is a disease of both veterinary and human importance. Here, we describe a method to continuously culture laboratory lines and field isolates of Babesia bovis in vitro in a chemically defined medium using (ALBU)MAX II as an alternative to bovine serum. Further, we have successfully cultured parasite isolates directly from cattle that failed to grow in traditional serum-containing medium. Variation of atmospheric gas composition and culture volumes to determine optimal growth conditions revealed that a 600-microl culture in an atmosphere comprising 5% O(2), 5% CO(2), and 90% N(2) achieved a significantly higher percentage of parasitized red blood cells than any other combination tested. The process could be scaled up to reliably produce large volumes of parasites. Supplementation of the culture medium with hypoxanthine further improved parasite growth. B. bovis cultured in this way could be the basis of an alternative, safer vaccine and a reliable source of parasites and exoantigens for parasitological research.
Asunto(s)
Babesia bovis/crecimiento & desarrollo , Animales , Bovinos , Criopreservación , Medios de Cultivo , Eritrocitos/parasitología , Gases , Hipoxantina/metabolismo , Distribución Aleatoria , Factores de TiempoRESUMEN
OBJECTIVE: To assess the efficacy of ivermectin and moxidectin to prevent transmission of Babesia bovis and Babesia bigemina by Boophilus microplus to cattle under conditions of relatively intense experimental challenge. DESIGN: Naive Bos taurus calves were treated with either pour-on or injectable formulations of either ivermectin or moxidectin and then exposed to larvae of B microplus infected with B bovis or larvae or adults of B microplus infected with B bigemina. One calf was used for each combination of haemoparasite, B microplus life stage, drug and application route. PROCEDURE: Groups of calves were treated with the test drugs in either pour-on or injectable formulation and then infested with B microplus larvae infected with B bovis or B bigemina. B bigemina infected adult male ticks grown on an untreated calf were later transferred to a fourth group of animals. Infections were monitored via peripheral blood smears to determine haemoparasite transmission. RESULTS: Cattle treated with either pour-on or injectable formulations of ivermectin and moxidectin became infected with B bovis after infestation with infected larvae. Similarly, larvae infected with B bigemina survived to the nymphal stage to transmit the haemoparasite to animals treated with each drug preparation. Cattle treated with pour-on formulations of ivermectin and moxidectin then infested with adult male ticks infected with B bigemina did not become infected with B bigemina whereas those treated with the injectable formulations of ivermectin and moxidectin did show a parasitaemia. CONCLUSIONS: Injectable or pour-on formulations of ivermectin and moxidectin do not prevent transmission of Babesia to cattle by B microplus. Use of these drugs can therefore not be recommended as a primary means of protecting susceptible cattle from the risk of Babesia infection.
Asunto(s)
Antiprotozoarios/administración & dosificación , Babesiosis/transmisión , Enfermedades de los Bovinos/transmisión , Insecticidas/administración & dosificación , Ivermectina/administración & dosificación , Administración Cutánea , Animales , Antibacterianos/administración & dosificación , Vectores Arácnidos/parasitología , Babesia/aislamiento & purificación , Babesiosis/prevención & control , Bovinos , Enfermedades de los Bovinos/parasitología , Enfermedades de los Bovinos/prevención & control , ADN Protozoario/aislamiento & purificación , Técnica del Anticuerpo Fluorescente Indirecta/veterinaria , Inyecciones Subcutáneas/veterinaria , Macrólidos , Masculino , Garrapatas/parasitologíaRESUMEN
An enzyme-linked immunosorbent assay (ELISA) for antibodies to Babesia bovis was evaluated in comparison with the indirect fluorescent antibody test (IFAT) in Australia and Zimbabwe. Positive and negative threshold values for the ELISA were set using sera from cattle of known infection status. Sensitivity and specificity estimates for the ELISA based on 158 positive sera from cattle experimentally infected with Australian isolates of B. bovis and 318 negative sera collected from B. bovis-free herds in Australia were 100% and 99.4%, respectively. The specificity of the assay in Africa, based on 328 sera from B. bovis-free herds in Kenya and South Africa, was 99.7%. The ELISA was compared with the IFAT using sequential sera from 16 calves experiencing primary B. bovis infections, and a total of 777 field sera collected from B. bovis-endemic herds in Australia and Zimbabwe. In primary infections, the ELISA and IFAT detected antibodies at or about the same time. With sera from endemic herds, the performance of the ELISA was at least comparable with that of the IFAT. Two hundred and fourteen of 221 sera that were negative by IFAT, were negative by ELISA, and 428 of 439 sera that were clearly positive by IFAT were positive by ELISA. Of 117 sera that gave equivocal (suspect or weak positive) results in the IFAT, 20 were positive by ELISA, 7 were suspect and 90 were negative. We conclude that the ELISA will be useful for epidemiological studies on B. bovis in Australia and Zimbabwe, and probably elsewhere.
Asunto(s)
Anticuerpos Antiprotozoarios/análisis , Babesia bovis/inmunología , Babesiosis/diagnóstico , Enfermedades de los Bovinos/diagnóstico , Ensayo de Inmunoadsorción Enzimática/veterinaria , Animales , Anticuerpos Antiprotozoarios/sangre , Australia/epidemiología , Babesiosis/epidemiología , Bovinos , Enfermedades de los Bovinos/epidemiología , Estudios de Evaluación como Asunto , Técnica del Anticuerpo Fluorescente Indirecta/veterinaria , Kenia/epidemiología , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Sudáfrica/epidemiología , Factores de Tiempo , Zimbabwe/epidemiologíaRESUMEN
Antigenic differences among Australian vaccine and field strains of Babesia bovis were investigated in an attempt to identify strain specific antigens. Immunoblots revealed substantial differences between the current vaccine strains, designated T and Dixie, and previous vaccine strains and field isolates collected on properties where vaccination with the T or Dixie strains had failed to provide complete protection against tick-borne challenge. A major difference was an immunodominant 40 kDa antigen (T40) present in only the T and Dixie strains. The molecular weight and immunodominant nature of this antigen suggest that it may be the equivalent of the major merozoite surface antigen (MSA-1) described by others in North American strains of B. bovis. MSA-1 was shown to be conserved in north American isolates but not in an isolate from Israel or in the Australian S and L isolates. The work presented here suggests that merozoite surface antigen diversity exists among geographically different isolates of B. bovis within Australia. Monospecific antiserum to T40 was used to develop an indirect fluorescent antibody (IFA) test specific for T and Dixie strain parasites, and a blocking enzyme-linked immunosorbent assay (ELISA) specific for antibody to the T and Dixie strains. In cases of babesiosis in recently vaccinated cattle, the IFA test will be a useful tool for determining whether clinical symptoms are due to a severe vaccine reaction or to a concurrent tick-borne infection. In a preliminary assessment of potential of the ELISA for the serological identification of vaccinated cattle using a total of 160 sera, the test clearly differentiated between animals vaccinated with the T or Dixie strains and non-vaccinated animals, and was not affected by presence of antibodies to other B. bovis strains.
Asunto(s)
Antígenos de Protozoos/análisis , Antígenos de Protozoos/inmunología , Babesia bovis , Babesiosis/diagnóstico , Enfermedades de los Bovinos , Vacunas Antiprotozoos , Animales , Australia , Babesia bovis/inmunología , Babesia bovis/aislamiento & purificación , Babesiosis/inmunología , Bovinos , Electroforesis en Gel de Poliacrilamida , Ensayo de Inmunoadsorción Enzimática , Técnica del Anticuerpo Fluorescente Indirecta , Immunoblotting , Peso Molecular , América del Norte , Queensland , Especificidad de la Especie , Vacunas AtenuadasRESUMEN
On nine separate occasions, Babesia bovis microaerophilus stationary phase (MASP) cultures were initiated with blood from calves with concurrent infections of B. bovis and Theileria buffeli, Eperythrozoon wenyoni or Anaplasma spp. In each case B. bovis became established in culture and was maintained for 30-49 days. Culture material was inoculated into susceptible splenectomised calves to test for persistence of the other organisms. No haemoparasites other than B. bovis were detected in Giemsa-stained blood films of recipient calves and no antibodies to T. buffeli or Anaplasma were detected using indirect fluorescent antibody and card agglutination tests, respectively. The method provides a practical way of removing contaminants such as Theileria, Eperythrozoon and Anaplasma spp. from B. bovis isolates without the use of drugs, tick passage or repeated syringe passage in cattle.
Asunto(s)
Babesia bovis/aislamiento & purificación , Babesiosis/parasitología , Enfermedades de los Bovinos/parasitología , Anaplasma/aislamiento & purificación , Anaplasmosis/complicaciones , Anaplasmosis/microbiología , Animales , Babesiosis/sangre , Babesiosis/complicaciones , Bovinos , Enfermedades de los Bovinos/sangre , Enfermedades de los Bovinos/microbiología , Medios de Cultivo , Mycoplasma/aislamiento & purificación , Infecciones por Mycoplasma/complicaciones , Infecciones por Mycoplasma/microbiología , Infecciones por Mycoplasma/veterinaria , Theileria/aislamiento & purificación , Theileriosis/complicaciones , Theileriosis/parasitologíaAsunto(s)
Anaplasma/inmunología , Babesia/inmunología , Vacunas Bacterianas/efectos adversos , Enfermedades de los Bovinos/prevención & control , Medios de Cultivo Condicionados/farmacología , Vacunas Antiprotozoos/efectos adversos , Tetraciclina/uso terapéutico , Anaplasmosis/prevención & control , Animales , Babesiosis/prevención & control , Bovinos , Enfermedades de los Bovinos/etiología , Contraindicaciones , Masculino , Vacunas Atenuadas/efectos adversosRESUMEN
An Australian Babesia bigemina vaccine strain was maintained in suspension culture for 40 days. Parasite growth was compared using two tissue-culture flask sizes (25 and 75 cm2), four gas mixes (2%, 2.5%, 3% and 3.5% O2; 5% CO2; and the balance N2) and four packed blood cell (PCV) volumes (7%, 9%, 13% and 18%). The best continuous parasite yields were obtained from suspension cultures in 75-cm2 flasks at a PCV of 13% and gas mixtures of 2%-3% O2, 5% CO2 and the balance N2. Parasite yields per millilitre of culture medium were 3 times those obtained in microaerophilous stationary-phase cultures. The method has thus far been used for 6 months to produce the Australian requirements for live B. bigemina vaccine.